These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 10613655)

  • 1. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural analysis of thrombin-induced interaction between human platelets and liposomes carrying fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
    Suzuki H; Okamura Y; Ikeda Y; Takeoka S; Handa M
    Thromb Res; 2011 Dec; 128(6):552-9. PubMed ID: 21840573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoration of fibrinogen γ-chain peptide on adenosine diphosphate-encapsulated liposomes enhances binding of the liposomes to activated platelets.
    Tokutomi K; Tagawa T; Korenaga M; Chiba M; Asai T; Watanabe N; Takeoka S; Handa M; Ikeda Y; Oku N
    Int J Pharm; 2011 Apr; 407(1-2):151-7. PubMed ID: 21251962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat platelets.
    Tokutomi K; Tagawa T; Korenaga M; Chiba M; Asai T; Watanabe N; Takeoka S; Handa M; Ikeda Y; Oku N
    Int J Pharm; 2012 Nov; 438(1-2):296-301. PubMed ID: 22985603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of disagregin with the platelet fibrinogen receptor, glycoprotein IIb-IIIa.
    Karczewski J; Connolly TM
    Biochem Biophys Res Commun; 1997 Dec; 241(3):744-8. PubMed ID: 9434779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
    Wittig K; Rothe G; Schmitz G
    Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
    J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
    Frojmovic MM; Wong T; Searcy GP
    Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
    Chiang TM; Zhu J
    Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo.
    Okamura Y; Maekawa I; Teramura Y; Maruyama H; Handa M; Ikeda Y; Takeoka S
    Bioconjug Chem; 2005; 16(6):1589-96. PubMed ID: 16287259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
    Mousa SA; Bozarth JM; Lorelli W; Forsythe MS; Thoolen MJ; Slee AM; Reilly TM; Friedman PA
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1277-84. PubMed ID: 9732389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
    Nakatanl S; Hato T; Minamoto Y; Fujita S
    Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
    Xiao Z; Théroux P; Frojmovic M
    Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.